| 臺大學術典藏 |
2022-03-04T05:33:41Z |
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
|
Wu S.-G.; Chang Y.-L.; Lin J.-W.; CHEN-TU WU; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2022-03-04T05:33:41Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.; Wu S.-G.; Chang Y.-L.; CHEN-TU WU; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-03-04T05:33:31Z |
Attenuation of lymphocyte immune responses during Mycobacterium avium complex-induced lung disease due to increasing expression of programmed death-1 on lymphocytes
|
Shu C.-C.; Wang J.-Y.; Wu M.-F.; CHEN-TU WU; Lai H.-C.; Lee L.-N.; Chiang B.-L.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:28Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-01T08:19:56Z |
Incidence and significance of clinically abnormal events in a Tertiary Referral Medical Center: Implementation of the Clinical Alert System (CAS)
|
Jerng J.-S.; Ko W.-J.; Lu F.L.; Chen Y.-S.; Huang S.-F.; Yu C.-J.; MING-JIUH WANG; Lin F.-Y. |
| 臺大學術典藏 |
2022-02-21T03:52:43Z |
Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer
|
JIH-HSIANG LEE; Yu C.-J.; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:42Z |
Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations
|
Wu S.-G.; Yang C.-H.; Yu C.-J.; JIH-HSIANG LEE; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-21T03:52:39Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
JIH-HSIANG LEE; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:38Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao B.-C.; JIH-HSIANG LEE; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; JIH-HSIANG LEE; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
JIH-HSIANG LEE; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
|
Chang H.-C.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:39Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J. |
| 臺大學術典藏 |
2022-02-08T03:50:28Z |
Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress
|
Yu C.-J.; Chun-Jung Ko; Hsieh C.-H.; Chien C.-T.; Huang L.-H.; Lee C.-W.; Jiang C.-C. |
| 臺大學術典藏 |
2022-01-25T03:25:09Z |
Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Liu H.-W.; Chen Y.-J.; Lai Y.-C.; Huang C.-Y.; Huang Y.-L.; Lin M.-T.; Han S.-Y.; CHI-LING CHEN; Yu C.-J.; Lee P.-L. |
| 臺大學術典藏 |
2022-01-25T03:25:05Z |
Timely diagnosis and treatment of sleep apnea reduce cardiovascular sequelae in patients with myocardial infarction
|
Lin M.-T.; Lai C.-L.; Lee P.-L.; Shen M.-H.; Yu C.-J.; Fang C.-T.; CHI-LING CHEN |
| 臺大學術典藏 |
2022-01-14T03:59:36Z |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
JO-PAI CHEN; Lo Y.; Yu C.-J.; Hsu C.; Shih J.-Y.; Yang C.-H. |
| 臺大學術典藏 |
2022-01-12T08:51:07Z |
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
|
Huang T.T.-M.; Chien Y.-C.; Wang C.-H.; Chang S.-Y.; Wang J.-T.; SONG-CHOU HSIEH; Yeh Y.-C.; Ku S.-C.; Yu C.-J.; Chiang B.-L.; Chang S.-C.; Tolwani A. |
| 臺大學術典藏 |
2022-01-12T03:53:04Z |
Air-polluted environmental heavy metal exposure increase lung cancer incidence and mortality: A population-based longitudinal cohort study
|
Lee N.-W.; Wang H.-Y.; Du C.-L.; Yuan T.-H.; Chen C.-Y.; Yu C.-J.; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2022-01-07T06:05:53Z |
Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study
|
Shu C.-C.; Hsu C.-L.; CHIH-YUAN LEE; Wang J.-Y.; Wu V.-C.; Yang F.-J.; Wang J.-T.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2022-01-07T06:05:51Z |
Risk of tuberculosis among patients on dialysis
|
Shu C.-C.; Hsu C.-L.; Wei Y.-F.; CHIH-YUAN LEE; Liou H.-H.; Wu V.-C.; Yang F.-J.; Lin H.-H.; Wang J.-Y.; Chen J.-S.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2022-01-07T06:05:50Z |
Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population
|
Shu C.-C.; Hsu C.-L.; CHIH-YUAN LEE; Wu V.-C.; Yang F.-J.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2022-01-07T06:05:47Z |
CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
|
Wang P.-H.; Lin S.-Y.; Lee S.S.-J.; Lin S.-W.; CHIH-YUAN LEE; Wei Y.-F.; Shu C.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2022-01-07T06:05:47Z |
Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: A neglected perspective in tuberculosis control
|
Shu C.-C.; Tsai M.-K.; Lin S.-W.; Wang J.-Y.; Yu C.-J.; CHIH-YUAN LEE |
| 臺大學術典藏 |
2022-01-07T06:05:46Z |
Completion and adverse drug events of latent tuberculosis infection treatment in patients receiving dialysis: Predictors and impacts of different regimens in a prospective cohort study
|
Lin S.-Y.; Feng J.-Y.; CHIH-YUAN LEE; Lin Y.-C.; Chou Y.-H.; Lin K.-Y.; Wei Y.-F.; Lin S.-W.; Chang C.-H.; Wang P.-H.; Shu C.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-12-30T06:50:54Z |
Elastase induces lung epithelial cell autophagy through placental growth factor A new insight of emphysema pathogenesis
|
Hou H.-H.; Cheng S.-L.; Chung K.-P.; Kuo M.Y.-P.; Yeh C.-C.; BEI-EN CHANG; Lu H.-H.; Wang H.-C.; Yu C.-J. |
| 臺大學術典藏 |
2021-12-01T06:03:22Z |
Life-threatening scrub typhus with meningoencephalitis and acute respiratory distress syndrome
|
Fang C.-T.; Ferng W.-F.; Hwang J.-J.; Yu C.-J.; YEE-CHUN CHEN; Wang M.-H.; Chang S.-C.; Hsieh W.-C. |
| 臺大學術典藏 |
2021-12-01T06:03:09Z |
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
|
Wang J.-T.; Sheng W.-H.; Fang C.-T.; YEE-CHUN CHEN; Wang J.-L.; Yu C.-J.; Chang S.-C.; Yang P.-C. |
| 臺大學術典藏 |
2021-11-30T04:54:25Z |
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease
|
Shu C.-C.; Lee L.-N.; Wu M.-F.; Lee C.-H.; Wang J.-T.; Wang J.-Y.; Yu C.-J.; Lee L.-N.; Yang P.-C.; Su W.-J.; Lai H.-C.; VIN-CENT WU; Yu M.-C. |
| 臺大學術典藏 |
2021-11-30T04:54:13Z |
Increased Risk of Active Tuberculosis following Acute Kidney Injury: A Nationwide, Population-Based Study
|
VIN-CENT WU; Wang C.-Y.; Shiao C.-C.; Chang C.-H.; Huang H.-Y.; Huang T.-M.; Lai C.-F.; Lin M.-C.; Ko W.-J.; Wu K.-D.; Yu C.-J.; Shu C.-C.; Lee C.-H.; Wang J.-Y. |
| 臺大學術典藏 |
2021-11-30T04:54:11Z |
Dynamic changes in positive interferon-gamma release assay in a dialysis population: An observational cohort study
|
Shu C.-C.; VIN-CENT WU; Yang F.-J.; Hsu C.-L.; Pan S.-C.; Wang J.-Y.; Wang J.-T.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-11-30T04:54:08Z |
Acute kidney injury due to anti-tuberculosis drugs: A five-year experience in an aging population
|
Chang C.-H.; Chen Y.-F.; VIN-CENT WU; Shu C.-C.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-11-30T04:54:02Z |
Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study
|
Shu C.-C.; Hsu C.-L.; Lee C.-Y.; Wang J.-Y.; VIN-CENT WU; Yang F.-J.; Wang J.-T.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-11-30T04:53:55Z |
Risk of tuberculosis among patients on dialysis
|
Shu C.-C.; Hsu C.-L.; Wei Y.-F.; Lee C.-Y.; Liou H.-H.; VIN-CENT WU; Yang F.-J.; Lin H.-H.; Wang J.-Y.; Chen J.-S.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-11-30T04:53:51Z |
Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population
|
Shu C.-C.; Hsu C.-L.; Lee C.-Y.; VIN-CENT WU; Yang F.-J.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-11-03T02:33:03Z |
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life
|
Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; JIN-YUAN SHIH; Hsiao F.-H. |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
|
Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; Chih-Hsin Yang J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T02:33:01Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
Lee M.-R.; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-11-03T02:32:58Z |
Tyrosine kinase inhibitors improved survival of critically ill egfr-mutant lung cancer patients undergoing mechanical ventilation
|
Lee I.-H.; Yang C.-Y.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2021-10-08T08:16:13Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; MONG-WEI LIN; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J. |
